Internal Medicine, Endocrinology, Diabetes, & Metabolism · Boston, MA
NPI
1801879945
Since 2005
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
2
Medicare group memberships
Hospitals
0
Hospital affiliations
133 Brookline Ave
Boston, MA, 02215
Phone (617) 421-1380
Groups this clinician bills Medicare through
Medicare paid, 2024
$225K
16,120 services
Medicare patients, 2024
381
Average age 74
Drug cost, 2024
$915K
2,530 prescriptions
Company payments, 2025
$448
From 4 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Rachael L Fawcett was code J0897 (injection, denosumab, 1 mg), 3,360 times for 32 patients. In total Rachael L Fawcett billed 16,120 services in 75 codes, and Medicare paid $225K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-02-10.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0897 Injection, denosumab, 1 mg | Office | 3,360 | 32 | $20.19 | $68K |
| 99214 Office E&M - Established | Office | 312 | 242 | $99.36 | $31K |
| 36415 Venipuncture Blood Collection | Office | 260 | 182 | $8.65 | $2,249 |
| 82310 Clinical Chemistry | Office | 153 | 111 | $5.06 | $774 |
| 96372 Injection Administration | Office | 147 | 38 | $12.62 | $1,856 |
| 83735 Clinical Chemistry | Office | 138 | 104 | $6.57 | $907 |
| 84100 Clinical Chemistry | Office | 136 | 101 | $4.65 | $632 |
| 84443 Clinical Chemistry | Office | 125 | 86 | $16.25 | $2,032 |
| 82565 Clinical Chemistry | Office | 125 | 100 | $5.02 | $628 |
| 82040 Clinical Chemistry | Office | 122 | 94 | $4.85 | $592 |
| 95251 Test - Miscellaneous | Office | 82 | 45 | $27.88 | $2,286 |
| 84479 Clinical Chemistry | Office | 63 | 44 | $6.34 | $399 |
| 84436 Clinical Chemistry | Office | 63 | 44 | $6.73 | $424 |
| 76536 Ultrasound - Nonspecific | Office | 61 | 60 | $88.45 | $5,395 |
| 83036 Blood Count | Office | 48 | 27 | $9.52 | $457 |
By year: 2022 $152K for 8,680 services; 2023 $176K for 10,493 services; 2024 $225K for 16,120 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 260 | 182 | $8.65 | $2,249 |
| 82310 Clinical Chemistry | 153 | 111 | $5.06 | $774 |
| 83735 Clinical Chemistry | 138 | 104 | $6.57 | $907 |
| 84100 Clinical Chemistry | 136 | 101 | $4.65 | $632 |
| 82565 Clinical Chemistry | 125 | 100 | $5.02 | $628 |
| 84443 Clinical Chemistry | 125 | 86 | $16.25 | $2,032 |
| 82040 Clinical Chemistry | 122 | 94 | $4.85 | $592 |
| 84436 Clinical Chemistry | 63 | 44 | $6.73 | $424 |
| 84479 Clinical Chemistry | 63 | 44 | $6.34 | $399 |
| 83036 Blood Count | 48 | 27 | $9.52 | $457 |
Medicare prescription drug claims, 2024
In 2024, the drug Rachael L Fawcett prescribed most often to Medicare patients was Levothyroxine Sodium, with 356 prescriptions and refills. In total Rachael L Fawcett wrote 2,530 Medicare prescriptions that cost $915K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 356 | 927 | 93 | $4,570 |
| Trulicity Dulaglutide | 206 | 242 | 38 | $229K |
| Mounjaro Tirzepatide | 132 | 152 | 18 | $157K |
| Metformin Hcl Er Metformin Hcl | 120 | 293 | 38 | $2,909 |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 117 | 214 | 35 | $12K |
| Repaglinide Generic | 111 | 240 | 35 | $2,498 |
| Ozempic Semaglutide | 99 | 116 | 22 | $107K |
| Humalog Kwikpen U-100 Insulin Lispro | 79 | 131 | 28 | $19K |
| Metformin Hcl Generic | 78 | 171 | 23 | $586 |
| Jardiance Empagliflozin | 77 | 106 | 16 | $63K |
| Testosterone Generic | 75 | 84 | 13 | $13K |
| Glipizide Generic | 66 | 118 | 17 | $727 |
| Nano 2nd Gen Pen Needle Pen Needle, Diabetic | 64 | 133 | 28 | $5,279 |
| Ultra-Fine Mini Pen Needle Pen Needle, Diabetic | 59 | 122 | 23 | $6,516 |
| Humulin N Kwikpen Insulin Nph Human Isophane | 58 | 115 | 18 | $13K |
Brand drugs: 1,266 claims; generic drugs: 1,010 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Rachael L Fawcett $448 ($448 in general payments such as food, travel and fees) from 4 companies. The largest payer was Medtronic, Inc. with $192.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.